FDA approves Teva leukemia drugReuters(Reuters) - The U.S. Food and Drug Administration on Friday said it has approved a new leukemia treatment from Teva Pharmaceutical Industries Ltd to be sold under the brand name Synribo. The drug, also known as omacetaxine mepesuccinate,
...and more »
0 comments:
Post a Comment